AXIOS April 29, 2024
Tina Reed

The prices of blockbuster drugs used for weight loss are gaining increased scrutiny as the universe of Americans who could receive these treatments expands.

Why it matters: With the drugs now available for heart risks and potentially soon for other conditions such as sleep apnea, there’s urgent discussion about how to pay for treatments that are hailed as revolutionary but have budget-busting potential.

  • “It’s almost hard to imagine what it could mean for total spending on prescription drugs,” said Tricia Neuman, senior vice president at health policy research nonprofit KFF.

Driving the news: The head of Congress’ budget scorekeeper last week said the net costs of the drugs — that is, after any rebates and discounts — would...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma / Biotech, Pricing / Spending, Provider
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article